Autoimmune hepatitis (AIH) is an unresolving progressive liver disease of unknown etiology
characterized by hypergammaglobulinemia, autoantibodies detection and interface …

Background Autoimmune hepatitis (AIH) is a disease of unknown aetiology characterised by
interface hepatitis, hypergammaglobulinaemia, circulating autoantibodies and a favourable …

Autoimmune hepatitis (AIH) is an immune-mediated liver disorder characterised by female
preponderance, elevated transaminase and immunoglobulin G levels, seropositivity for …

The transcription factor forkhead box protein 3 (FOXP3) is an essential molecular marker of
regulatory T cell (Treg) development in different microenvironments. Tregs are cells …

Autoimmune hepatitis (AIH) in humans is a severe inflammatory liver disease characterized
by interface hepatitis, the presence of circulating autoantibodies, and hyper …

Autoimmune hepatitis (AIH) is a severe and chronic liver disease, and its incidence has
increased worldwide in recent years. Research into the pathogenesis of AIH remains limited …

The immune system responds differently in women and in men. Generally speaking, adult
females show stronger innate and adaptive immune responses than males. This results in …

Autoimmune hepatitis (AIH) is known as a T cell–mediated disease. However, AIH patients
refractory to conventional treatment have been successfully treated with anti‐CD20 …

Autoimmune hepatitis (AIH) is characterized by a loss of immunological tolerance to
hepatocytes. Patients respond well to immunosuppression but progression to endstage liver …

This study is aimed at examining the potential role of regulatory T‐(Treg‐) Th1‐Th17‐Th22
cells in the pathogenic process of autoimmune hepatitis (AIH). The numbers of Foxp3+ …